<table width="800px" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 9 Established and Other Potentially Significant Drug Interactions with Ganciclovir</caption>
<col width="1px"></col>
<col width="1px"></col>
<col width="1px"></col>
<tbody>
<tr>
<td align="center" stylecode="     Toprule         Lrule          Rrule     ">
<paragraph>
<content stylecode="bold">Name of </content>
<content stylecode="bold">the</content>
<content stylecode="bold"> <br/>
</content>
<content stylecode="bold">Concomit</content>
<content stylecode="bold">a</content>
<content stylecode="bold">nt Drug</content>
</paragraph>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     "> <content stylecode="bold">Change in the Concentration of</content>
<content stylecode="bold"> </content>
<content stylecode="bold">Ganciclovir or </content>
<br/>
<content stylecode="bold">Concomitant Drug</content>
</td>
<td stylecode="     Toprule         Lrule          Rrule     " valign="top"> <content stylecode="bold">Clinical Comment</content>
</td>
</tr>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     "> Zidovudine</td>
<td stylecode="     Toprule         Lrule          Rrule     ">↓ Ganciclovir <br/>↑ Zidovudine</td>
<td stylecode="     Toprule         Lrule          Rrule     ">Zidovudine and Valganciclovir each have the potential to cause neutropenia and anemia</td>
</tr>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     "> Probenecid</td>
<td stylecode="     Toprule         Lrule          Rrule     ">↑ Ganciclovir</td>
<td stylecode="     Toprule         Lrule          Rrule     ">Patients taking probenecid and Valganciclovir should be monitored for evidence of ganciclovir toxicity</td>
</tr>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     " valign="top"> Mycophenolate <br/> Mofetil (MMF)</td>
<td stylecode="     Toprule         Lrule          Rrule     ">↔ Ganciclovir (in patients with normal renal function)<br/>↔ MMF (in patients with normal renal function)</td>
<td stylecode="     Toprule         Lrule          Rrule     ">Patients with renal impairment should be monitored carefully as levels of MMF metabolites and ganciclovir may increase</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     "> Didanosine</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">↓ Ganciclovir <br/>↑ Didanosine</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Patients should be closely monitored for didanosine toxicity</td>
</tr>
</tbody>
</table>